<html>
<head>
<title>out.html</title>
</head>
<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>``We wanted to see if an effect would be observed with
Verapamil,'' said Dr. Forgen Fischer Hansen of Copenhagen Municipal
Hospital</a><br>
</a>
</a>
</body>
</html>
<a name="2">[2]</a> <a href="#2" id=2>``This ultimately makes it possible for patients to be
treated in community hospitals and be transfered to terciary care
centers if angioplasty is needed,'' said Dr. Howard Morgan,
immediate past president of the heart association</a><br>
</a>
</a>
</body>
</html>
<a name="3">[3]</a> <a href="#3" id=3>``This trial has settled one of the most important questions in
modern-day cardiology,'' commented Dr. J</a><br>
</a>
</a>
</body>
</html>
<a name="4">[4]</a> <a href="#4" id=4>``There does not appear to be any additional benefit from
angioplasty,'' Braunwald said</a><br>
</a>
</a>
</body>
</html>
<a name="5">[5]</a> <a href="#5" id=5>``Then it levels off</a><br>
</a>
</a>
</body>
</html>
<a name="6">[6]</a> <a href="#6" id=6>``The watch word is watchful waiting'' to see if patients need
angioplasty</a><br>
</a>
</a>
</body>
</html>
<a name="7">[7]</a> <a href="#7" id=7>``We now know when to prescribe this drug and when not to,''
Moss said</a><br>
</a>
</a>
</body>
</html>
<a name="8">[8]</a> <a href="#8" id=8>``That's what this study was all about.'</a><br>
</a>
</a>
</body>
</html>
<a name="9">[9]</a> <a href="#9" id=9>Ward Kennedy of the
University of Washington, Seattle</a><br>
</a>
</a>
</body>
</html>
<a name="10">[10]</a> <a href="#10" id=10>While small hospitals can give clot-dissolving drugs to heart
attack patients, most of them do not have the sophisticated labs
where angioplasty is performed</a><br>
</a>
</a>
</body>
</html>
<a name="11">[11]</a> <a href="#11" id=11>The study is phase 2 of the Thrombolysis in Miocardial Infarction
Trial, or TIMI-II, directed by Dr. Eugene Braunwald of Brigham and
Women's Hospital in Boston</a><br>
</a>
</a>
</body>
</html>
<a name="12">[12]</a> <a href="#12" id=12>The study found that if heart attack victims quickly receive
clot-dissolving drugs, they usually don't need the extra step of the
common balloon procedure, known as angioplasty.</a><br>
</a>
</a>
</body>
</html>
